CD30-targeting immunoconjugates and bystander effects
- PMID: 25734636
- DOI: 10.1038/nrclinonc.2014.159-c1
CD30-targeting immunoconjugates and bystander effects
Comment on
-
The development of immunoconjugates for targeted cancer therapy.Nat Rev Clin Oncol. 2014 Nov;11(11):637-48. doi: 10.1038/nrclinonc.2014.159. Epub 2014 Sep 30. Nat Rev Clin Oncol. 2014. PMID: 25265912 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
